Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 12
Out of 5,241 analysts
137
Total ratings
57.29%
Success rate
153.01%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QDEL QuidelOrtho | Downgrades: Hold | $35 → $13 | $11.38 | +9.84% | 7 | May 7, 2026 | |
| TEM Tempus AI | Initiates: Underperform | $35 | $45.53 | -23.13% | 1 | Apr 13, 2026 | |
| VCYT Veracyte | Initiates: Buy | $45 | $41.69 | +7.94% | 1 | Apr 13, 2026 | |
| CAI Caris Life Sciences | Initiates: Buy | $28 | $14.96 | +87.17% | 1 | Apr 13, 2026 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 → $1,450 | $1,050.77 | +37.99% | 9 | Mar 20, 2026 | |
| DGX Quest Diagnostics | Maintains: Buy | $215 → $220 | $190.39 | +15.55% | 4 | Feb 11, 2026 | |
| RVTY Revvity | Maintains: Hold | $100 → $105 | $95.87 | +9.52% | 2 | Feb 3, 2026 | |
| DHR Danaher | Maintains: Overweight | $270 → $275 | $167.04 | +64.63% | 5 | Jan 29, 2026 | |
| AVTR Avantor | Downgrades: Underperform | $12 → $9 | $7.64 | +17.80% | 1 | Dec 17, 2025 | |
| BLLN BillionToOne | Initiates: Hold | $117 | $82.29 | +42.18% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $435 → $385 | $333.26 | +15.53% | 8 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $160 → $155 | $110.57 | +40.18% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $80 | $42.13 | +89.89% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $290 | $253.69 | +14.31% | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $8.39 | +162.22% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $41 → $53 | $34.24 | +54.70% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $49.50 | -29.29% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $22.29 | +7.67% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.15 | +247.83% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $2.38 | +26.05% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $196.04 | -27.57% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $98.19 | -67.41% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $141.68 | -18.83% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $3.55 | +463.38% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $447.81 | +45.15% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $15.23 | -40.91% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.98 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.68 | +614.29% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $2.51 | +2,290.44% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.68 | +391.45% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $152.43 | +155.86% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.08 | +484.42% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $441.58 | -54.71% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $23.05 | +4.12% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $9.74 | +362.01% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $108.52 | -35.50% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $173.18 | -30.71% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.2858 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $42.59 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $9.66 | +469.36% | 1 | Jul 19, 2016 |
QuidelOrtho
May 7, 2026
Downgrades: Hold
Price Target: $35 → $13
Current: $11.38
Upside: +9.84%
Tempus AI
Apr 13, 2026
Initiates: Underperform
Price Target: $35
Current: $45.53
Upside: -23.13%
Veracyte
Apr 13, 2026
Initiates: Buy
Price Target: $45
Current: $41.69
Upside: +7.94%
Caris Life Sciences
Apr 13, 2026
Initiates: Buy
Price Target: $28
Current: $14.96
Upside: +87.17%
Mettler-Toledo International
Mar 20, 2026
Upgrades: Buy
Price Target: $1,400 → $1,450
Current: $1,050.77
Upside: +37.99%
Quest Diagnostics
Feb 11, 2026
Maintains: Buy
Price Target: $215 → $220
Current: $190.39
Upside: +15.55%
Revvity
Feb 3, 2026
Maintains: Hold
Price Target: $100 → $105
Current: $95.87
Upside: +9.52%
Danaher
Jan 29, 2026
Maintains: Overweight
Price Target: $270 → $275
Current: $167.04
Upside: +64.63%
Avantor
Dec 17, 2025
Downgrades: Underperform
Price Target: $12 → $9
Current: $7.64
Upside: +17.80%
BillionToOne
Dec 1, 2025
Initiates: Hold
Price Target: $117
Current: $82.29
Upside: +42.18%
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $333.26
Upside: +15.53%
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $110.57
Upside: +40.18%
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $42.13
Upside: +89.89%
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $253.69
Upside: +14.31%
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $8.39
Upside: +162.22%
Dec 10, 2024
Assumes: Buy
Price Target: $41 → $53
Current: $34.24
Upside: +54.70%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $49.50
Upside: -29.29%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $22.29
Upside: +7.67%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.15
Upside: +247.83%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $2.38
Upside: +26.05%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $196.04
Upside: -27.57%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $98.19
Upside: -67.41%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $141.68
Upside: -18.83%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $3.55
Upside: +463.38%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $447.81
Upside: +45.15%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $15.23
Upside: -40.91%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.98
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.68
Upside: +614.29%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $2.51
Upside: +2,290.44%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.68
Upside: +391.45%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $152.43
Upside: +155.86%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.08
Upside: +484.42%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $441.58
Upside: -54.71%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $23.05
Upside: +4.12%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $9.74
Upside: +362.01%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $108.52
Upside: -35.50%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $173.18
Upside: -30.71%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $0.2858
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $42.59
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $9.66
Upside: +469.36%